European Parliament · 24 November 2021
A pharmaceutical strategy for Europe
Adopted
527 in favour · 92 against · 70 abstained. 689 members voted.
What it asks for, in the Parliament's words
- Calls on the Commission to support pricing models which take account of real production costs
- Calls on the Commission to promote the development of research in the field of pain therapy drugs
- Calls on the Commission to develop clear guidance on the role of procurement policy in promoting greener pharmaceuticals
Quoted from A9-0317/2021, which says more than these lines. Each is a whole paragraph; this site does not rewrite them.
See how every country and every MEP voted